ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2605
Delayed Data
As of Jun 18
 -0.0095 / -3.52%
Today’s Change
0.17
Today|||52-Week Range
2.79
-17.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization47.7K36.2K75.1K47.8K
 
 
 
 
 
 
Operating ExpensesGross Income-47.7K-36.2K-75.1K-47.8K
 
 
 
 
 
General Expenses9.8M15.5M24.0M18.8M
 
 
 
 
 
Research And Development6.0M10.9M19.1M14.8M
 
 
 
 
 
Total Operating Expenses9.9M15.5M24.1M18.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-15.5M-24.1M-18.8M
 
 
 
 
 
Extraordinary Credit529.8K2.9M3.8M7.7M
 
 
 
 
 
Extraordinary Charge--0.000.00-2.3M
 
 
Interest Expense On Debt--222.8K1.8M882.7K
 
 
 
 
Other Expenses-62.7K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.4M-12.8M-22.1M-14.3M
 
 
 
 
 
Preferred Dividend0.000.000.00-3.3M
 
 
Net Income-9.4M-12.8M-22.1M-14.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.2M2.8M14.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.2M2.8M14.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.40-$6.00-$7.89-$1.23
 
 
 
 
 
EPS Diluted-$6.40-$6.00-$7.89-$1.23